#alzheimers-drug

[ follow ]
www.nytimes.com
6 months ago
Artificial intelligence

Medicine, Technology and the End of Cancer

The FDA has approved an Alzheimer's drug for the first time in two decades.
Cancer treatment has drastically changed, but a highly effective therapy remains elusive for most patients. [ more ]
www.nytimes.com
6 months ago
Medicine

Medicine, Technology and the End of Cancer

The FDA has approved an Alzheimer's drug for the first time in two decades.
Cancer treatment has drastically changed, but a highly effective therapy remains elusive for most patients. [ more ]
www.nytimes.com
6 months ago
Health

Medicine, Technology and the End of Cancer

The FDA has approved an Alzheimer's drug for the first time in two decades.
Cancer treatment has drastically changed, but a highly effective therapy remains elusive for most patients. [ more ]
www.nytimes.com
6 months ago
Health

Medicine, Technology and the End of Cancer

The FDA has approved an Alzheimer's drug for the first time in two decades.
Cancer treatment has drastically changed, but a highly effective therapy remains elusive for most patients. [ more ]
www.nytimes.com
6 months ago
Health

Medicine, Technology and the End of Cancer

The FDA has approved an Alzheimer's drug for the first time in two decades.
Cancer treatment has drastically changed, but a highly effective therapy remains elusive for most patients. [ more ]
#fda-approval
www.nytimes.com
2 weeks ago
Medicine

A Drug to Slow Alzheimer's Is Finally Available. How Are Patients Faring?

The Alzheimer's drug lecanemab offers hope with modest benefits and high risks, as strict criteria determine patient eligibility. [ more ]
ABC7 San Francisco
2 weeks ago
OMG science

Alzheimer's drug that can slow disease gets backing from FDA advisers

FDA advisers backed Alzheimer's drug from Eli Lilly, suggesting approval for mild dementia treatment. [ more ]
www.npr.org
2 weeks ago
US news

FDA advisors strongly back new Alzheimer's drug, despite risks and limitations

FDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression. [ more ]
www.nytimes.com
2 weeks ago
Medicine

A Drug to Slow Alzheimer's Is Finally Available. How Are Patients Faring?

The Alzheimer's drug lecanemab offers hope with modest benefits and high risks, as strict criteria determine patient eligibility. [ more ]
ABC7 San Francisco
2 weeks ago
OMG science

Alzheimer's drug that can slow disease gets backing from FDA advisers

FDA advisers backed Alzheimer's drug from Eli Lilly, suggesting approval for mild dementia treatment. [ more ]
www.npr.org
2 weeks ago
US news

FDA advisors strongly back new Alzheimer's drug, despite risks and limitations

FDA advisors recommend approval of Alzheimer's drug donanemab for slowing disease progression. [ more ]
morefda-approval
[ Load more ]